PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and...
Year: 2023
Aeterna Zentaris Reports Third Quarter 2023 Financial Results
- Launch of Ghryvelin™ in a number of key countries in the European Economic Area - Approval of Macrilen® in...
Survey Finds Nearly 1 in 2 Americans are Concerned About Contracting an Infectious Disease from a Hospital
Results land amidst surge in drug-resistant organisms and fungal outbreaks, showcase widespread concerns about infection risks in hospitalsBrooklyn, N.Y., Nov....
Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume
Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE)...
Collegium Announces $25 Million Accelerated Share Repurchase Program
STOUGHTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed...
Dentsply Sirona to Host its Investor Day and Introduce Three-Year Financial Targets
CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host...
Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
-- Blocking of α5β1 integrin has been shown to improve motor function and increase survival in the SOD1G93A mouse model of...
My Crew Doses Inc. Announces the No Fallen Heroes Partnership and Addition of Key Strategic Investors and Advisors
Jupiter, Florida--(Newsfile Corp. - November 9, 2023) - My Crew Doses Inc., (the "Company" or "MCD"), an American PhD-led brand...
AlzeCure Publishes its Interim Report for January – September 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
The Subscription Period in Spago Nanomedical’s Rights Issue Begins Today
NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG-KONG, JAPAN, CANADA, SWITZERLAND,...
Stakeholders Endorse First-Ever Declaration on Self-Care for Universal Health Coverage
SAO PAULO / ACCESSWIRE / November 9, 2023 / The Global Self-Care Federation (GSCF) and the United for Self-Care Coalition...
Angle PLC Announces Trading and Business Update
Revenue recognised for 2023 expected to be up 120% at c. £2.2 million with sales secured in 2023 expected to...
Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to...
Former Amryt Pharma Leadership Team join Poolbeg
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg PharmaPoolbeg team boosted by highly experienced executives with track...
Smartphones and Smart Speakers May Be Able to Detect Alcohol Intoxication by Analyzing Voice Patterns: Study
PISCATAWAY, NJ / ACCESSWIRE / November 9, 2023 / Sensors in smartphones and smart speakers could help determine a person's...
LFTD Partners Inc. to Host Conference Call on Monday, November 13, 2023 to Discuss Q3 2023 Financial Results
JACKSONVILLE, FL / ACCESSWIRE / November 8, 2023 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB:LIFD), the corporate...
Medexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Million
Fiscal Q2 2024 revenue reflects a 9.4% increase over fiscal Q2 2023, demonstrating strong revenue growth and continued overall performanceManagement...
Inspire Veterinary Partners Announces Acquisition of Valley Veterinary Service Animal Hospital
Latest acquisition brings the total number of Inspire locations to 14.Expansion into a new state, Pennsylvania.Pipeline of attractive potential acquisitions...
Planet 13 Announces Q3 2023 Financial Results
Q3 2023 Revenue of $24.8 millionQ3 2023 Net loss of $46.0 million, which included a non-cash impairment loss of $39.6...
Moderna to Present at Upcoming Conferences in November 2023
CAMBRIDGE, MA / ACCESSWIRE / November 8, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming...